1. Home
  2. TURN vs SER Comparison

TURN vs SER Comparison

Compare TURN & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TURN
  • SER
  • Stock Information
  • Founded
  • TURN 1981
  • SER 2017
  • Country
  • TURN United States
  • SER United States
  • Employees
  • TURN 8
  • SER N/A
  • Industry
  • TURN Finance/Investors Services
  • SER Biotechnology: Pharmaceutical Preparations
  • Sector
  • TURN Finance
  • SER Health Care
  • Exchange
  • TURN Nasdaq
  • SER Nasdaq
  • Market Cap
  • TURN 49.6M
  • SER 53.1M
  • IPO Year
  • TURN N/A
  • SER 2018
  • Fundamental
  • Price
  • TURN $4.96
  • SER $5.11
  • Analyst Decision
  • TURN
  • SER Strong Buy
  • Analyst Count
  • TURN 0
  • SER 2
  • Target Price
  • TURN N/A
  • SER $13.00
  • AVG Volume (30 Days)
  • TURN 33.1K
  • SER 338.0K
  • Earning Date
  • TURN 02-26-2018
  • SER 11-11-2025
  • Dividend Yield
  • TURN N/A
  • SER N/A
  • EPS Growth
  • TURN N/A
  • SER N/A
  • EPS
  • TURN 0.29
  • SER N/A
  • Revenue
  • TURN $488,011.00
  • SER $130,000.00
  • Revenue This Year
  • TURN N/A
  • SER N/A
  • Revenue Next Year
  • TURN N/A
  • SER N/A
  • P/E Ratio
  • TURN $17.34
  • SER N/A
  • Revenue Growth
  • TURN 277.43
  • SER N/A
  • 52 Week Low
  • TURN $3.12
  • SER $3.81
  • 52 Week High
  • TURN $5.01
  • SER $10.28
  • Technical
  • Relative Strength Index (RSI)
  • TURN 67.09
  • SER 45.65
  • Support Level
  • TURN $4.51
  • SER $4.90
  • Resistance Level
  • TURN $4.90
  • SER $5.25
  • Average True Range (ATR)
  • TURN 0.17
  • SER 0.51
  • MACD
  • TURN -0.01
  • SER -0.01
  • Stochastic Oscillator
  • TURN 90.00
  • SER 12.31

About TURN 180 Degree Capital Corp.

180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: